IKS Health, backed by the Jhunjhunwala family and RARE Enterprises, made a stunning stock market debut on December 19.
The stock opened at ₹1,900 on NSE, surging 42.96% above its issue price of ₹1,329, and gained 39.65% on BSE. Late Rakesh Jhunjhunwala had invested $5.5 million in 2007, a stake now valued at $1.4 billion. The Jhunjhunwala family retains a 50% stake post-listing, cementing their legacy in the healthcare solutions firm’s phenomenal success.